Literature DB >> 13782950

Malignant effusions treated by colloidal radioactive yttrium silicate.

J WALTER.   

Abstract

Entities:  

Keywords:  EXUDATES AND TRANSUDATES; NEOPLASMS/radiotherapy; YTTRIUM/radioactive

Mesh：

Substances：

Year:  1960        PMID： 13782950      PMCID： PMC2097028          DOI： 10.1136/bmj.2.5208.1282

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  A comparison of the tissue distribution of colloidal yttrium-90 and gold-198 in mice after intraperitoneal injection.

Authors:  G B COOK; B J MILES; F E NEAL; A R THOMSON
Journal:  Strahlentherapie       Date:  1958

2.  Radioyttrium (Y90) for the palliative treatment of effusions due to malignancy.

Authors:  E P SIEGEL; H E HART; M BROTHERS; H SPENCER; D LASZLO
Journal:  J Am Med Assoc       Date:  1956-06-09

3.  Biological studies on stable and radioactive rare earth compounds. III. Distribution of radioactive yttrium in normal and ascites-tumor-bearing mice, and in cancer patients with serous effusions.

Authors:  R LEWIN; H E HART; J GREENBERG; H SPENCER; K G STERN; D LASZLO
Journal:  J Natl Cancer Inst       Date:  1954-08       Impact factor: 13.506

4.  Radioactive gold in malignant effusions.

Authors:  J WALTER
Journal:  Proc R Soc Med       Date:  1953-06

5.  Distribution of colloidal radioactive chromic phosphate after intracavitary administration.

Authors:  S W ROOT; M P TYOR; G A ANDREWS; R M KNISELEY
Journal:  Radiology       Date:  1954-08       Impact factor: 11.105
  5 in total
  2 in total

1.  THE LATE EFFECTS OF IRRADIATION--CLINICAL ASPECTS. CARCINOMA OF THE CERVIX.

Authors:  K A NEWTON
Journal:  Proc R Soc Med       Date:  1964-07

2.  The management of malignant pleural effusion.

Authors:  M L Sutton
Journal:  Postgrad Med J       Date:  1973-10       Impact factor: 2.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.